Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6286 to 6300 of 7680 results

  1. Urinary incontinence: the management of urinary incontinence in women (CG40)

    This guidance has been updated and replaced by NICE guideline CG171.

  2. Familial breast cancer (CG41)

    This guidance has been updated and replaced by NICE guideline CG164.

  3. Dementia: supporting people with dementia and their carers in health and social care (CG42)

    This guidance has been updated and replaced by NICE guideline NG97.

  4. Heavy menstrual bleeding: assessment and management (CG44)

    This guidance has been updated and replaced by NICE guideline NG88.

  5. Antenatal and postnatal mental health: Clinical management and service guidance (CG45)

    This guidance has been updated and replaced by NICE guideline CG192.

  6. Venous thromboembolism (surgical) (CG46)

    This guidance has been updated and replaced by NICE guideline CG92.

  7. Feverish illness in children: assessment and initial management in children younger than 5 years (CG47)

    This guidance has been updated and replaced by NICE guideline CG160.

  8. COVID-19 rapid evidence summary: Remdesivir for treating hospitalised patients with suspected or confirmed COVID-19 (ES27)

    This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.

  9. COVID-19 rapid evidence summary: vitamin D for COVID-19 (ES28)

    This evidence summary has been updated and replaced by the COVID-19 rapid guideline on vitamin D (NG187).

  10. COVID-19 rapid evidence summary: Tocilizumab for COVID-19 (ES33)

    This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.

  11. COVID-19 rapid evidence summary: Sarilumab for COVID-19 (ES34)

    This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.

  12. Excessive daytime sleepiness in Parkinson's disease: modafinil (ESUOM48)

    This evidence summary has been updated and replaced by NICE guideline NG71.

  13. Postural hypotension in adults: midodrine (ESUOM5)

    This evidence summary has been updated and replaced by NICE evidence summary: new medicines 61.

  14. Hormone-sensitive metastatic prostate cancer: docetaxel (ESUOM50)

    This evidence summary has been updated and replaced by NICE guideline NG131.